Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BRTX will decline by -31.22% over the next 2 Weeks and hit $0.15 by Tuesday, September 1, 2026. In that time frame, BRTX's share price is expected to range between $0.12 and $0.17.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 1, 2026 | 0.12 | 0.15 | 0.17 |
| Aug 31, 2026 | 0.13 | 0.15 | 0.18 |
| Aug 28, 2026 | 0.14 | 0.17 | 0.19 |
| Aug 27, 2026 | 0.15 | 0.18 | 0.20 |
| Aug 26, 2026 | 0.15 | 0.18 | 0.20 |
| Aug 25, 2026 | 0.15 | 0.18 | 0.21 |
| Aug 24, 2026 | 0.16 | 0.19 | 0.21 |
| Aug 21, 2026 | 0.17 | 0.20 | 0.22 |
| Aug 20, 2026 | 0.18 | 0.21 | 0.23 |
| Aug 19, 2026 | 0.18 | 0.21 | 0.23 |
BRTX shares rose +6.01% in Wednesday, August 19, 2026's trading session, rising from a previous close of $0.21 to move at $0.23. The stock demonstrated notable intraday movement (see BRTX's key stats for a full breakdown), fluctuating between $0.22 and $0.23, a +3.83% trading range. While recent weeks have seen some volatility, BRTX has managed to secure a +7.52% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 0 shares changing hands, 224.37K fewer than the previous session. This amounted to $0.00 in total market activity.
Will BRTX Continue Its Downward Trend?
According to analyst ratings and projections for BRTX, BioRestorative Therapies, Inc. shares are anticipated to decrease by -31.46%, potentially reaching $0.17 per share by September 1, 2026. Short-term technical indicators for BRTX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 21 negative trading days within the past 30 sessions. Based on the BRTX stock forecast, now is not the best time to buy BRTX stock because its current trading price is +54.13% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BRTX covering social and institutional perspectives.
BRTX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BRTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.47% to 41.22%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 42.02%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 42.49%, maintains a neutral outlook for the long term. Insights into BRTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioRestorative Therapies Short-Term Forecasts
BRTX Forecast For Next 5 Days
Our algorithm anticipates BioRestorative Therapies (BRTX) stock could hit $0.22 by Aug 26, 2026. This represents a -2.66% fall from today's price, following a -5.27% change over the past five days.
BRTX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BioRestorative Therapies, Inc. (BRTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.17, which would mean a -24.71% decrease from the current price of $0.23. Projections for this period range from a high of $0.28 to a low of $0.07.
BRTX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BioRestorative Therapies's price over the next three months point to a rise. BRTX stock is expected to peak at $0.97 on Aug 20, 2026 before potentially dipping to $0.30 on Nov 12, 2026. On average, BRTX is likely to trade around $0.61 in the coming 90 days.
BioRestorative Therapies Stock Forecast 2025
Based on our predictive models, BioRestorative Therapies (BRTX) is expected to trade between $0.17 and $0.97 throughout 2026. This would result in an average price of $0.52, potentially offering investors a +130.29% return from current levels.
BioRestorative Therapies, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.74 and $0.97, settling at an average of $0.86. This could translate to a +280.87% gain.
September 2026
Based on current market signals, BioRestorative Therapies, Inc. is projected to trend september 2026. We forecast a trading range from $0.55 to $0.85, with a likely average price of $0.68. Investors could expect a potential return of +201.15%.
October 2026
Our predictive algorithms indicate BioRestorative Therapies, Inc. stock may see a shift in October 2026. The expected range spans $0.37–$0.71, with an average target of $0.56. This represents a positive outlook and a possible gain of +148.01%.
November 2026
Analyzing established trends, BioRestorative Therapies, Inc. looks set to move in November 2026. Projections place the stock between $0.26 and $0.53, averaging around $0.39. This suggests a +72.72% gain from current levels.
December 2026
Market indicators suggest BioRestorative Therapies, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.17 to $0.41, with a midpoint forecast of $0.30. The stock might deliver a +32.86% gain.
January 2027
Forecasting for January 2027, models estimate that BioRestorative Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.11 and $0.31, averaging $0.24. This signals a positive trajectory with potential returns around +6.29%.
February 2027
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.04 and $0.27, settling at an average of $0.18. This could translate to a -20.28% loss.
March 2027
Based on current market signals, BioRestorative Therapies, Inc. is projected to trend march 2027. We forecast a trading range from $0.00 to $0.20, with a likely average price of $0.13. Investors could expect a potential return of -42.43%.
April 2027
Our predictive algorithms indicate BioRestorative Therapies, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$0.14, with an average target of $0.09. This represents a cautious outlook and a possible loss of -60.14%.
May 2027
Analyzing established trends, BioRestorative Therapies, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $0.11, averaging around $0.07. This suggests a -69.00% loss from current levels.
June 2027
Market indicators suggest BioRestorative Therapies, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $0.05, with a midpoint forecast of $0.05. The stock might deliver a -77.86% loss.
July 2027
Forecasting for July 2027, models estimate that BioRestorative Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.04. This signals a cautious trajectory with potential returns around -82.29%.
August 2027
According to our latest forecast models, BioRestorative Therapies, Inc. (BRTX) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.03. This could translate to a -86.71% loss.
BRTX's history of dividends and stock splits also plays a role in long-term investor confidence.

